Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 USD | -3.36% |
|
-12.95% | +25.90% |
20/06 | Sector Update: Health Care Stocks Mixed Thursday Afternoon | MT |
20/06 | ImmunityBio Shares Rise After Launch of Bladder Cancer Treatment Anktiva in US | MT |
Evolution of the average Target Price on ImmunityBio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering ImmunityBio, Inc.
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- IBRX Stock
- Consensus ImmunityBio, Inc.